EPITA encourages applications from either diabetes physicians or nephrologists with an interest in Beta Cell Replacement Therapy or transplant surgeons.
EPITA, the European Pancreas and Islet Transplant Association, wishes to announce a call for nominations for a new Board member. The mandate of the new EPITA Board Member is 4 years (2021-2025). Given the current composition of the EPITA Board, and to ensure that all relevant specialties are represented, applications from diabetes (transplant) physicians will be
On March 5th 2021, ESOT opened a tender for a technical provider that will build the multi-organ registry. ESOT is seeking the support of additional European national authorities and expect to finalise agreement with participating countries by the end of April 2021. In addition, ESOT is establishing contacts with non-European countries and registries. read more
The abstract submission deadline for #ESOTcongress has been EXTENDED until Thursday 25th February at 23:59 CET.
Transplant patients are exceptionally vulnerable to all infections, especially COVID-19, due to immunosuppression and other co-morbidities. There is a clear need for these patients to receive the best available protection against COVID-19 and we strongly believe that they should be considered as a priority group for vaccination across Europe. Furthermore, our patients and the broader
ESOT is seeking a publisher for its flagship scientific journal, Transplant International, to discuss the transition to an open access journal.
EKHA Open Letter to EU Policymakers On Behalf Of The European Organ Donation and Transplantation Community “Life After Covid-19: Time to realise a Second EU Action Plan on Organ Donation and Transplantation” EKHA Open Letter on Organ Donation & Transplantation
ESOT is pleased to announce a new initiative in collaboration with the Centre for Evidence in Transplantation (CET), allowing 40 prospective abstract submitters to receive preliminary feedback on their abstract to help enhance the quality and increase the chances of being accepted to the Congress. Please see the process and deadlines below: Any prospective abstract
We are delighted to inform you that the 2021 edition of the Hesperis course will take place online, in an innovative and exciting format. Learn more about the features that make Hesperis 2021 a unique educational opportunity for emerging professionals: from anywhere across Europe and beyond, learners will be able to gain an extensive overview
The ESOT Congress serves as a premier platform for researchers from across the globe to present their organ transplantation research, the abstract submission is open, with the following key submission deadlines: Abstract submission: 22 February 2021 Late-breaking abstract submission period: 10-25 May 2021 (preliminary research must be provided by 22 February 2021) Find out more by reading our abstract and clinical